Insights

Biosimilar Market Expansion Alvotech has been actively expanding its biosimilar portfolio, recently launching UZPROVO and partnering with companies like Dr. Reddy's Laboratories and Quallent Pharmaceuticals Health. This signifies a growing market presence and partnership opportunities for sales expansion.

Global Outreach Through collaborations with international companies like STADA Arzeimittel AG, Alvotech has broadened its reach across Europe, Canada, Japan, and the US. Such global partnerships offer avenues for sales teams to explore new markets and establish strategic alliances.

Strategic Product Development Alvotech's focus on developing high-demand biosimilars like AVT29 (EYLEA) and SIMLANDI injection demonstrates a strategic approach to meeting market needs. Sales professionals can leverage these innovative products to engage with healthcare providers and drive sales growth.

Financial Stability With a revenue range of $100M to 1B and significant funding of $900M, Alvotech displays financial robustness. This financial stability provides a solid foundation for sales expansion initiatives and instills confidence in potential partners and investors.

Competitive Advantage In a landscape with similar biotechnology research companies like Aurobindo Pharma and Coherus BioSciences, Alvotech stands out with its diverse biosimilar portfolio and strategic collaborations. Sales teams can capitalize on this competitive edge to position Alvotech as a preferred partner in the industry.

Alvotech Tech Stack

Alvotech uses 8 technology products and services including Cookiebot, SAP, amCharts, and more. Explore Alvotech's tech stack below.

  • Cookiebot
    Cookie Compliance
  • SAP
    Customer Relationship Management
  • amCharts
    Javascript Graphics
  • Cisco
    Network Hardware
  • Java
    Programming Languages
  • reCAPTCHA
    Security
  • Minitab
    Visualisation Software
  • FlexSlider
    Widgets

Media & News

Alvotech's Email Address Formats

Alvotech uses at least 1 format(s):
Alvotech Email FormatsExamplePercentage
First.Last@alvotech.comJohn.Doe@alvotech.com
98%
FirstLa@alvotech.comJohnDo@alvotech.com
1%
First@alvotech.comJohn@alvotech.com
1%

Frequently Asked Questions

Where is Alvotech's headquarters located?

Minus sign iconPlus sign icon
Alvotech's main headquarters is located at Saemundargata 15-19 Reykjavik, - 101 IS. The company has employees across 6 continents, including EuropeAsiaNorth America.

What is Alvotech's phone number?

Minus sign iconPlus sign icon
You can contact Alvotech's main corporate office by phone at +354-522-2900. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Alvotech's stock symbol?

Minus sign iconPlus sign icon
Alvotech is a publicly traded company; the company's stock symbol is ALVO.

What is Alvotech's official website and social media links?

Minus sign iconPlus sign icon
Alvotech's official website is alvotech.com and has social profiles on LinkedIn.

How much revenue does Alvotech generate?

Minus sign iconPlus sign icon
As of September 2024, Alvotech's annual revenue reached $750M.

What is Alvotech's SIC code NAICS code?

Minus sign iconPlus sign icon
Alvotech's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Alvotech have currently?

Minus sign iconPlus sign icon
As of September 2024, Alvotech has approximately 880 employees across 6 continents, including EuropeAsiaNorth America. Key team members include Chief Executive Officer: R. W.Chief Technical Officer: G. Z.Chief Scientific Officer: J. M.. Explore Alvotech's employee directory with LeadIQ.

What industry does Alvotech belong to?

Minus sign iconPlus sign icon
Alvotech operates in the Biotechnology Research industry.

What technology does Alvotech use?

Minus sign iconPlus sign icon
Alvotech's tech stack includes CookiebotSAPamChartsCiscoJavareCAPTCHAMinitabFlexSlider.

What is Alvotech's email format?

Minus sign iconPlus sign icon
Alvotech's email format typically follows the pattern of . Find more Alvotech email formats with LeadIQ.

How much funding has Alvotech raised to date?

Minus sign iconPlus sign icon
As of September 2024, Alvotech has raised $965M in funding. The last funding round occurred on Jun 07, 2024 for $965M.

When was Alvotech founded?

Minus sign iconPlus sign icon
Alvotech was founded in 2013.
Alvotech

Alvotech

Biotechnology Research-, Iceland501-1000 Employees

Our mission is to improve patient lives and the sustainability of the global healthcare ecosystem by broadening the availability and accessibility of biosimilars.

Section iconCompany Overview

Headquarters
Saemundargata 15-19 Reykjavik, - 101 IS
Phone number
+354-522-2900
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ALVO
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
501-1000

Section iconFunding & Financials

  • $965M

    Alvotech has raised a total of $965M of funding over 8 rounds. Their latest funding round was raised on Jun 07, 2024 in the amount of $965M.

  • $100M$1B

    Alvotech's revenue is in the range of $100M$1B

Section iconFunding & Financials

  • $965M

    Alvotech has raised a total of $965M of funding over 8 rounds. Their latest funding round was raised on Jun 07, 2024 in the amount of $965M.

  • $100M$1B

    Alvotech's revenue is in the range of $100M$1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.